Clinical Trial Update: Heparin's Influence on ROTEM® Analysis

View source ↗

Summary

The trial reports on the influence of heparin on ROTEM analysis in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University of Lausanne Hospitals | Conditions: Coronary Artery Disease | Status: COMPLETED